SCHEMBL6599564

SCHEMBL6599564

CNc1nc(/N=N/c2ccc(Cl)c(CNS(C)(=O)=O)c2)ncc1[N+](=O)[O-]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCQ Q04759 10/20 0.37
▸ MAPT P10636 3/20 0.34
▸ VCAM1 P19320 3/20 0.34
▸ POLB P06746 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ PLA2G2A P14555 1/20 0.34
▸ P2RY1 P47900 1/20 0.34
▸ P2RY13 Q9BPV8 1/20 0.34
▸ CYP3A4 P08684 3/20 0.33
▸ CYP2C9 P11712 3/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ DCLK1 O15075 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ MATK P42679 1/20 0.33
▸ FRK P42685 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599566 1.00 PRKCQ (0.37) PRKCQMAPTVCAM1POLBSMN1; SMN2
SCHEMBL5413674 0.79 STK17A (0.45) PRKCQMAPTSMN1; SMN2CYP3A4CYP2C9
SCHEMBL3182626 0.65 PRKCQ (0.50) PRKCQMAPTPOLBSMN1; SMN2PKM
SCHEMBL4867295 0.63 PIN1 (0.61) POLBSMN1; SMN2PKMGSK3BPIN1
Hydrochloric Acid SCHEMBL5422026 0.63 STK17A (0.53) PRKCQMAPTSMN1; SMN2CYP3A4CYP2C9
SCHEMBL3847319 0.62 PRKCQ (0.60) PRKCQMAPTPOLBCYP3A4CYP2C9
SCHEMBL5410032 0.62 GSK3B (0.54) PRKCQMAPTSMN1; SMN2CYP3A4CYP2C9
SCHEMBL3172877 0.61 MAPT (0.55) PRKCQMAPTPOLBSMN1; SMN2PKM
Alcohol SCHEMBL27702458 0.61 PIN1 (0.55) MAPTPOLBCYP3A4CYP2C9GSK3B
SCHEMBL16011456 0.61 L3MBTL1 (0.62) MAPTPOLBSMN1; SMN2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453516-A2 NOVEL TRI-SUBSTITUTED PYRIMIDINES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2004-09-08 — — EP disclosed
WO-2003032994-A2 NOVEL TRI-SUBSTITUTED PYRIMIDINES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-04-24 — — WO disclosed
Send feedback